🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ARQ 197 or placebo in combination with irinotecan and cetuximab in particip...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-26
Trial ID
NCT01075048
Treatments Being Tested
A study to investigate the safety and tolerability of both single and multi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-12
Trial ID
NCT00459550
Treatments Being Tested
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148
The purpose of this study is to determine the safety and effectiveness of T...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00760955
The goal of this clinical trial is to learn if a traditional Chinese herbal...
Status
Not Yet Recruiting
Location
Peking Union Medical College Hospital
Start Date
2026-01-01
Trial ID
NCT07347340
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo controlled, three arm ...
Status
Completed
Location
TriWest Research Associates, LLC
Start Date
2019-08-27
Trial ID
NCT04134091
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of TAK-438, once dail...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01452763
This is a multicenter study to test the hypothesis that suvorexant (MK-4305...
Status
Completed
Location
Multiple Locations
Start Date
2010-05-05
Trial ID
NCT01097616
Treatments Being Tested
This study will evaluate the safety, pharmacokinetics, and efficacy of thre...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2021-11-08
Trial ID
NCT05159908
Treatments Being Tested
This is a randomized, double blind, placebo and active (moxifloxacin open l...
Status
Completed
Location
Celerion, Inc.
Start Date
2023-07-11
Trial ID
NCT05927649
Treatments Being Tested